These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26177152)

  • 41. Long noncoding RNA in genome regulation: prospects and mechanisms.
    Hung T; Chang HY
    RNA Biol; 2010; 7(5):582-5. PubMed ID: 20930520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
    Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
    BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Xist RNA-PRC2 complex at 20-nm resolution reveals a low Xist stoichiometry and suggests a hit-and-run mechanism in mouse cells.
    Sunwoo H; Wu JY; Lee JT
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4216-25. PubMed ID: 26195790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA.
    Davidovich C; Wang X; Cifuentes-Rojas C; Goodrich KJ; Gooding AR; Lee JT; Cech TR
    Mol Cell; 2015 Feb; 57(3):552-8. PubMed ID: 25601759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis.
    Ounzain S; Micheletti R; Arnan C; Plaisance I; Cecchi D; Schroen B; Reverter F; Alexanian M; Gonzales C; Ng SY; Bussotti G; Pezzuto I; Notredame C; Heymans S; Guigó R; Johnson R; Pedrazzini T
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):98-112. PubMed ID: 26423156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification.
    Alekseyenko AA; Gorchakov AA; Kharchenko PV; Kuroda MI
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2488-93. PubMed ID: 24550272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EZH2 takes the stage when BRCA1 loses.
    Wang L; Huang H
    Cell Cycle; 2013 Dec; 12(23):3575-6. PubMed ID: 24121664
    [No Abstract]   [Full Text] [Related]  

  • 48. RNA binding of PRC2: promiscuous or well ordered?
    Kretz M; Meister G
    Mol Cell; 2014 Jul; 55(2):157-8. PubMed ID: 25038410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA
    Jin JJ; Lv W; Xia P; Xu ZY; Zheng AD; Wang XJ; Wang SS; Zeng R; Luo HM; Li GL; Zuo B
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9802-E9811. PubMed ID: 30279181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BRCA1 is a negative modulator of the PRC2 complex.
    Wang L; Zeng X; Chen S; Ding L; Zhong J; Zhao JC; Wang L; Sarver A; Koller A; Zhi J; Ma Y; Yu J; Chen J; Huang H
    EMBO J; 2013 May; 32(11):1584-97. PubMed ID: 23624935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards understanding of PRC2 binding to RNA.
    Yan J; Dutta B; Hee YT; Chng WJ
    RNA Biol; 2019 Feb; 16(2):176-184. PubMed ID: 30608221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.
    Khan SN; Jankowska AM; Mahfouz R; Dunbar AJ; Sugimoto Y; Hosono N; Hu Z; Cheriyath V; Vatolin S; Przychodzen B; Reu FJ; Saunthararajah Y; O'Keefe C; Sekeres MA; List AF; Moliterno AR; McDevitt MA; Maciejewski JP; Makishima H
    Leukemia; 2013 Jun; 27(6):1301-9. PubMed ID: 23486531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network.
    Hao A; Wang Y; Stovall DB; Wang Y; Sui G
    Int J Biol Sci; 2021; 17(13):3268-3280. PubMed ID: 34512145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatial separation of Xist RNA and polycomb proteins revealed by superresolution microscopy.
    Cerase A; Smeets D; Tang YA; Gdula M; Kraus F; Spivakov M; Moindrot B; Leleu M; Tattermusch A; Demmerle J; Nesterova TB; Green C; Otte AP; Schermelleh L; Brockdorff N
    Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2235-40. PubMed ID: 24469834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis.
    Sharma S; Mandal P; Sadhukhan T; Roy Chowdhury R; Ranjan Mondal N; Chakravarty B; Chatterjee T; Roy S; Sengupta S
    Sci Rep; 2015 Jul; 5():11724. PubMed ID: 26152361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
    Lavarone E; Barbieri CM; Pasini D
    Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
    Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
    Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing.
    Schoeftner S; Sengupta AK; Kubicek S; Mechtler K; Spahn L; Koseki H; Jenuwein T; Wutz A
    EMBO J; 2006 Jul; 25(13):3110-22. PubMed ID: 16763550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
    Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations.
    Wu H; Zeng H; Dong A; Li F; He H; Senisterra G; Seitova A; Duan S; Brown PJ; Vedadi M; Arrowsmith CH; Schapira M
    PLoS One; 2013; 8(12):e83737. PubMed ID: 24367611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.